Watch today

Omega Metabolism: Evolving Beyond EPA & DHA

Access

12 months

Format

Online Webinar

Duration

1 hour

Presenters

Camilla Brinkworth & Greg Cumberford

Essential fatty acids are imperative to human health and support the cardiovascular system, central nervous system, immune system, hormones and skin, but 90% of those on a Western diet are receiving inadequate or appropriately balanced intake. (1) The scientific focus has predominantly been on omega-3 EPA and DHA and their associated specialised pro-resolving mediators. However, the Global Organisation of Omega-3s EPA and DHA warned in 2022 that the oceans can’t provide even the most conservative recommended daily intake of EPA and DHA for each human being. Plant-based sources rich in omega-3 ALA do not provide EPA and DHA directly, and metabolise to EPA/DHA relatively inefficiently. (2) Algal sources predominantly offer DHA, typically with little EPA. (3)

Refined Buglossoides arvensis seed oil’s highest-available SDA content uniquely metabolises to EPA and DHA efficiently, providing the widest array of anti-inflammatory substrates and oxylipin precursors, including from EPA and DHA. (4, 5) We will review the benefits associated with valuable omega metabolites most practitioners overlook, including ALA, SDA, ETA, GLA and DGLA; whilst reviewing the literature demonstrating Buglossoides arvensis seed oil’s 4x more efficient conversion to EPA than flax (5), and efficient DHA biosynthesis in key tissues (liver, brain), comparably to a preformed marine DHA source. (4)

Learn how an ultra-sustainable, pleasant-tasting, plant-based oil could readily and efficiently meet our human EPA and DHA needs, whilst providing the broadest-spectrum of oxylipin precursors.

Join Camilla Brinkworth and Greg Cumberford in ‘Omega Metabolism- Evolving Beyond EPA & DHA.’

Proudly sponsored by

MEET YOUR PRESENTERS

Camilla Brinkworth

BHSc 
Camilla Brinkworth is a clinical naturopath with a BHSc (Naturopathy), currently undertaking an MSc (Human Nutrition). Camilla came across refined Buglossoides arvensis seed oil over three years ago and seeing its potential as a viable solution to our omega sustainability crisis, made it her mission to bring it to Australia and New Zealand as a novel TGA-approved ingredient; regulatory approval was granted in July 2023.  She has co-authored a number of articles on Ahiflower. Camilla specialises in plant-based nutrition and has a passion for healthcare which simultaneously promotes both human and planetary health.

Greg Cumberford

BSc, Vice President
Greg Cumberford is Vice President of Science & Regulatory at Natures Crops International. He has a 30+ year career in plant-based nutraceutical research, development, and commercialisation. He is responsible for university research liaisons with Ahiflower (refined Buglossoides arvensis seed oil). He has co-authored many peer-reviewed and industry journal articles describing Ahiflower oil’s fatty acids, clinical efficacy, and functional health benefits. He holds a BSc degree from Stanford University.
References
1. Gabbs M, Leng S, Devassy JG, Monirujjaman M, Aukema HM. Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs. Adv Nutr. 2015 Sep 15;6(5):513-40. doi: 10.3945/an.114.007732. PMID: 26374175; PMCID: PMC4561827.
2. Santos HO, Price JC, Bueno AA. Beyond Fish Oil Supplementation: The Effects of Alternative Plant Sources of Omega-3 Polyunsaturated Fatty Acids upon Lipid Indexes and Cardiometabolic Biomarkers-An Overview. Nutrients. 2020 Oct 16;12(10):3159. doi: 10.3390/nu12103159. PMID: 33081119; PMCID: PMC7602731.
3. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. Marine Oils. 2023 Nov 15. PMID: 30000958.
4. Metherel AH, Klievik BJ, Cisbani G, Smith ME, Cumberford G, Bazinet RP. Blood and tissue docosahexaenoic acid (DHA, 22:6n-3) turnover rates from Ahiflower® oil are not different than from DHA ethyl ester oil in a diet switch mouse model. Biochim Biophys Acta Mol Cell Biol Lipids. 2024 Jan;1869(1):159422. doi: 10.1016/j.bbalip.2023.159422. Epub 2023 Nov 17. PMID: 37977491.
5. Lefort N, LeBlanc R, Giroux MA, Surette ME. Consumption of Buglossoides arvensis seed oil is safe and increases tissue long-chain n-3 fatty acid content more than flax seed oil – results of a phase I randomised clinical trial. J Nutr Sci. 2016 Jan 8;5:e2. doi: 10.1017/jns.2015.34. PMID: 26793308; PMCID: PMC4709838.